Additionally, they treated liver disease with radiotherapy, anti-PD-L1, or a combination of both, observing an increased presence of interferon gamma production by CD4+ and CD8+ T cells in tumors treated with radiotherapy, hypothesizing that it could restore the efficacy of ICIs in this scenario. This evidence concerns the gene CD8A and liver disorder.